Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Promising TSX Penny Stocks To Consider In February 2025

In This Article:

The Canadian market is navigating a complex landscape, with tariffs posing potential risks to economic growth and inflation. Despite these challenges, opportunities for investors remain, particularly in the realm of penny stocks. While the term may seem outdated, these smaller or newer companies can offer significant growth potential when backed by strong financials and sound fundamentals.

Top 10 Penny Stocks In Canada

Name

Share Price

Market Cap

Financial Health Rating

Alvopetro Energy (TSXV:ALV)

CA$4.85

CA$177.31M

★★★★★★

Silvercorp Metals (TSX:SVM)

CA$4.60

CA$1B

★★★★★★

Mandalay Resources (TSX:MND)

CA$4.68

CA$439.49M

★★★★★★

Pulse Seismic (TSX:PSD)

CA$2.37

CA$120.49M

★★★★★★

Foraco International (TSX:FAR)

CA$2.40

CA$236.24M

★★★★★☆

Findev (TSXV:FDI)

CA$0.50

CA$14.32M

★★★★★★

PetroTal (TSX:TAL)

CA$0.69

CA$628.96M

★★★★★★

NamSys (TSXV:CTZ)

CA$0.97

CA$26.06M

★★★★★★

East West Petroleum (TSXV:EW)

CA$0.04

CA$3.62M

★★★★★★

DIRTT Environmental Solutions (TSX:DRT)

CA$1.18

CA$228.22M

★★★★☆☆

Click here to see the full list of 938 stocks from our TSX Penny Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

MediPharm Labs

Simply Wall St Financial Health Rating: ★★★★★★

Overview: MediPharm Labs Corp. is a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts and related products in Canada, Australia, Germany, and internationally, with a market cap of CA$28.78 million.

Operations: The company generates CA$39.05 million in revenue from the production and sale of cannabis extracts and derivative products.

Market Cap: CA$28.78M

MediPharm Labs Corp. is navigating the penny stock landscape with a market cap of CA$28.78 million and recent revenue of CA$39.05 million from cannabis extracts and derivatives. Despite being unprofitable, it has reduced losses over five years by 7.8% annually, maintaining a stable cash runway exceeding three years due to positive free cash flow trends. The company has more cash than debt, with short-term assets covering liabilities comfortably. A significant recent development is its commercial agreement with Laboratorio Teuto in Brazil, marking regulatory compliance achievements that could enhance its global footprint in medical cannabis markets.

TSX:LABS Financial Position Analysis as at Feb 2025
TSX:LABS Financial Position Analysis as at Feb 2025

Chesapeake Gold

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Chesapeake Gold Corp. is a mineral exploration and evaluation company that focuses on acquiring, evaluating, and developing precious metal deposits in North and Central America, with a market cap of CA$85.49 million.